Status:
NOT_YET_RECRUITING
Comparison of Retinal Damage in ICL Implantation Using 3D Visualization System vs. Microscope
Lead Sponsor:
Fuzhou Eye Hospital
Collaborating Sponsors:
Alcon Research
Conditions:
High Myopia
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
Implantable collamer lens (ICL) implantation is considered one of the most effective surgical treatments for high myopia. The procedure primarily involves adjusting the position of the ICL within the ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of high myopic
- Aged 18-40 years
- Desire to improve their refractive status via ICL surgery
- Relatively stable refractive error (change ≤ 0.50 D per year for two consecutive years)
- Central anterior chamber depth ≥ 2.8 mm
- Open angles
- Corneal endothelial cell density ≥ 2000 cells/mm2.
Exclusion
- Cataracts
- Corneal diseases,
- Glaucoma,
- Nystagmus,
- Strabismus,
- Lens subluxation,
- Severe vitreoretinal diseases,
- Other ocular diseases
- A history of ocular trauma
- A history of ocular surgery
Key Trial Info
Start Date :
August 25 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06966622
Start Date
August 25 2025
End Date
May 31 2026
Last Update
August 8 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.